Item 7.01. Regulation FD Disclosure
On
Item 9.01. Financial Statements and Exhibits.
(d)
Exhibits Item
99.1 Press release dated
© Edgar Online, source
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.06 USD | -7.83% | -1.29% | +7.75% |
May. 15 | Earnings Flash (AYTU) AYTU BIOPHARMA Reports Q3 Revenue $18M, vs. Street Est of $17.4M | MT |
Feb. 14 | Transcript : Aytu BioPharma, Inc., Q2 2024 Earnings Call, Feb 14, 2024 |
Item 7.01. Regulation FD Disclosure
On
Item 9.01. Financial Statements and Exhibits.
(d)
Exhibits Item
99.1 Press release dated
© Edgar Online, source
1st Jan change | Capi. | |
---|---|---|
+7.75% | 18.49M | |
+31.37% | 588B | |
-2.60% | 364B | |
+20.83% | 326B | |
+5.69% | 285B | |
+14.83% | 239B | |
+9.93% | 210B | |
-6.95% | 200B | |
+10.77% | 167B | |
+0.10% | 161B |